DK2921486T3 - Sammensætninger og fremgangsmåder til behandling af beta-amyloid-relaterede sygdomme - Google Patents
Sammensætninger og fremgangsmåder til behandling af beta-amyloid-relaterede sygdommeInfo
- Publication number
- DK2921486T3 DK2921486T3 DK14188202.7T DK14188202T DK2921486T3 DK 2921486 T3 DK2921486 T3 DK 2921486T3 DK 14188202 T DK14188202 T DK 14188202T DK 2921486 T3 DK2921486 T3 DK 2921486T3
- Authority
- DK
- Denmark
- Prior art keywords
- amyloid
- compositions
- methods
- related diseases
- treating beta
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/336—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/48—Compounds containing oxirane rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms, e.g. ester or nitrile radicals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US23238809P | 2009-08-07 | 2009-08-07 | |
| US23238309P | 2009-08-07 | 2009-08-07 | |
| US29378310P | 2010-01-11 | 2010-01-11 | |
| EP10807219.0A EP2462131B1 (en) | 2009-08-07 | 2010-08-06 | Compositions and methods for treating beta-amyloid related diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2921486T3 true DK2921486T3 (da) | 2017-11-13 |
Family
ID=43544958
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK14188202.7T DK2921486T3 (da) | 2009-08-07 | 2010-08-06 | Sammensætninger og fremgangsmåder til behandling af beta-amyloid-relaterede sygdomme |
| DK10807219.0T DK2462131T3 (da) | 2009-08-07 | 2010-08-06 | Præparater og fremgangsmåder til behandling af beta-amyloid-relaterede sygdomme |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK10807219.0T DK2462131T3 (da) | 2009-08-07 | 2010-08-06 | Præparater og fremgangsmåder til behandling af beta-amyloid-relaterede sygdomme |
Country Status (3)
| Country | Link |
|---|---|
| EP (3) | EP2462131B1 (da) |
| DK (2) | DK2921486T3 (da) |
| WO (1) | WO2011017600A2 (da) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015117094A1 (en) * | 2014-02-03 | 2015-08-06 | American Life Science Pharmaceuticals, Inc. | Compositions and methods for synthesizing (2s,3s)-trans-epoxysuccinyl-l-leucyl-amido-3-methylbutane ethyl ester |
| WO2016126662A1 (en) * | 2015-02-03 | 2016-08-11 | Kardiatonos, Inc. | Compounds for the prevention and treatment of vascular disease |
| US20190015361A1 (en) * | 2017-07-17 | 2019-01-17 | Maxwell Biosciences, Inc. | Polytherapy modulating cathelicidin gene exprtession modulation for the treatment of alzheimer's disease and other conditions |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1087725C (zh) * | 1994-03-25 | 2002-07-17 | 同位素技术有限公司 | 用氘代方法增强药物效果 |
| CN1491104A (zh) | 2001-02-13 | 2004-04-21 | 新型改进释放制剂 | |
| WO2003066859A2 (en) | 2002-02-07 | 2003-08-14 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Amino acid sequences capable of facilitating penetration across a biological barrier |
| DE10250084A1 (de) | 2002-10-25 | 2004-05-06 | Grünenthal GmbH | Gegen Missbrauch gesicherte Darreichungsform |
| WO2004084830A2 (en) * | 2003-03-21 | 2004-10-07 | Buck Institute | Method for treating alzheimer’s dementia |
| US8906413B2 (en) | 2003-05-12 | 2014-12-09 | Supernus Pharmaceuticals, Inc. | Drug formulations having reduced abuse potential |
| WO2004112747A2 (en) | 2003-06-24 | 2004-12-29 | Baxter International Inc. | Specific delivery of drugs to the brain |
| WO2006097793A2 (en) | 2004-04-15 | 2006-09-21 | Chiasma, Ltd. | Compositions capable of facilitating penetration across a biological barrier |
| WO2007038772A1 (en) * | 2005-09-28 | 2007-04-05 | American Life Science Pharmaceuticals | Novel drugs for dementia |
| CN101808634A (zh) | 2006-06-13 | 2010-08-18 | 利兰·斯坦福青年大学托管委员会 | 半胱氨酸蛋白酶的环氧化物抑制剂 |
| WO2008037072A1 (en) | 2006-09-25 | 2008-04-03 | Merck Frosst Canada Ltd. | Cathepsin b inhibitors |
| AU2008204335B2 (en) | 2007-01-11 | 2013-06-13 | Michael Bacher | Diagnosis and treatment of Alzheimer's and other neurodementing diseases |
-
2010
- 2010-08-06 EP EP10807219.0A patent/EP2462131B1/en not_active Not-in-force
- 2010-08-06 WO PCT/US2010/044683 patent/WO2011017600A2/en not_active Ceased
- 2010-08-06 DK DK14188202.7T patent/DK2921486T3/da active
- 2010-08-06 EP EP14188202.7A patent/EP2921486B1/en not_active Not-in-force
- 2010-08-06 EP EP17182879.1A patent/EP3296295A1/en not_active Withdrawn
- 2010-08-06 DK DK10807219.0T patent/DK2462131T3/da active
Also Published As
| Publication number | Publication date |
|---|---|
| WO2011017600A2 (en) | 2011-02-10 |
| EP2462131A2 (en) | 2012-06-13 |
| DK2462131T3 (da) | 2015-01-05 |
| EP2921486B1 (en) | 2017-09-27 |
| EP2462131B1 (en) | 2014-10-15 |
| EP2921486A1 (en) | 2015-09-23 |
| WO2011017600A3 (en) | 2011-06-16 |
| EP3296295A1 (en) | 2018-03-21 |
| EP2462131A4 (en) | 2013-01-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2894165T5 (da) | Fremgangsmåder og sammensætninger til behandling af komplementforbundne forstyrrelser | |
| DK3795573T3 (da) | Bestemte triazolopyraziner, sammensætninger deraf og fremgangsmåder til anvendelse deraf | |
| DK2473034T3 (da) | Frøbehandlingssammensætninger og fremgangsmåde | |
| DK2361090T3 (da) | Sammensætninger til behandling af centralt medieret kvalme og opkastning | |
| DK3128014T3 (da) | Midler og fremgangsmåder til sterilisering af biofunktionelle sammensætninger | |
| DK2323638T3 (da) | Sammensætninger og fremgangsmåder til behandling af osteoartritis | |
| DK2398902T3 (da) | Fremgangsmåder og sammensætninger til diagnosticering og behandling af cancer | |
| DK2796469T3 (da) | Hidtil ukendte sammensætninger og fremgangsmåder til behandling af IgE-medierede forstyrrelser | |
| DK2437742T3 (da) | Nye sammensætninger til behandling af cmt og beslægtede sygdomme | |
| PL2496691T3 (pl) | Terapeutyczne kompozycje nukleazy i sposoby | |
| DK2475372T4 (da) | Fremgangsmåde til fremstilling af micro-RNA og dets terapeutiske anvendelse | |
| DK2419732T3 (da) | Prionfrie nanopartikelsammensætninger og fremgangsmåder | |
| DK3444342T3 (da) | Fremgangsmåder og sammensætninger til behandlingen af lysosomale aflejringssygdomme | |
| DK2419670T3 (da) | Leveringsmetode og sammensætninger | |
| DK2419114T4 (da) | Bakteriesammensætninger til profylakse og behandling af degenerative sygdomme | |
| DK2252342T3 (da) | Indretninger og fremgangsmåder til behandling af skadet væv | |
| DK2699553T3 (da) | Substituerede diaminocarboxamid- og diaminocarbonitrilpyrimidiner, sammensætninger deraf og fremgangsmåder til behandling dermed | |
| DK2766483T3 (da) | Fremgangsmåder og sammensætninger til screening for og behandling af udviklingsforstyrrelser | |
| DK2473510T3 (da) | Jak-2-hæmmere og anvendelse heraf til behandling af myeloproliferativesygdomme og cancer | |
| DK3443957T3 (da) | Forbindelser og sammensætninger til behandling af cancer | |
| DK2504353T4 (da) | Lipopeptidsammensætninger og tilsvarende fremgangsmåder | |
| DK2445912T3 (da) | Ny forbindelse anvendelig til behandlingen af degenerative og inflammatoriske sygdomme | |
| BRPI0920284A2 (pt) | composição e método | |
| DK2408807T3 (da) | Fremgangsmåde til terapeutisk anvendelse | |
| DK2446246T3 (da) | Indretning og fremgangsmåde til udvælgelse af partikler |